Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy Volunteers

NCT03937648 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: COL-144 50mg
DRUG: COL-144 100mg
DRUG: COL-144 200mg
DRUG: COL-144 400mg
DRUG: Placebo

Sponsor

IlDong Pharmaceutical Co Ltd